APA e-Focus free CME: I Worry About Everything
Understanding the Evidence
A FREE CME Program
Get started on the fourth of 10 clinical vignettes: I Worry About Everything: Understanding the Evidence
Prescribing of atypical antipsychotics has expanded beyond the FDA approved indications, but their effectiveness, benefits, and adverse effects in off-label uses are not well understood. How do atypical antipsychotic medications compare with other drugs for "off-label" indications? This program can help!
The APA has developed a FREE CME program about evidence for effectiveness of off-label use of atypical antipsychotics, with grant support (#R18 HS021944) from the Agency for Healthcare Research and Quality (AHRQ). The goal of the program is to help physicians make informed treatment decisions based on the evidence for the off-label use of these medications. This interactive CME program is a part of a series of 10 multimedia clinical vignettes and a self-assessment test available for CME and self-assessment credit at www.APAeducation.org.
Clinicians who review the comprehensive AHRQ report and newer evidence for treatment with atypical antipsychotics, and complete the self-assessment test and all 10 clinical vignettes, can earn up to 25 AMA PRA Category 1 CreditsTM and MOC Part 2, Self-Assessment activity.
The APA is accredited by the ACCME to provide continuing medical education for physicians. The APA designates this enduring material for a maximum of 2 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity is approved by ABPN as a MOC Part 2, Self-Assessment activity.
Get started on the clinical vignette!
For more information click here: www.psychiatry.org/APAefocus.